MEDFASH partnered with St Stephen’s AIDS Trust to deliver Work Package 5, one of the project’s four core work packages. This aims to develop and pilot the implementation of tools to support indicator condition (IC) guided HIV testing in healthcare settings across the European region. The project’s focus is on testing in the following ICs which have the highest HIV prevalence rates in the priority regions/groups: hepatitis B and hepatitis C, infectious mononucleosis-like syndrome and pneumonia.
There is particular emphasis in the project on removing provider-based barriers to testing in order to increase the offer and uptake rates for HIV testing. The Work Package 5 team is working with pilot sites in the Czech Republic, Estonia, France, Greece, Poland, Spain and the UK. It is also working on the parallel OptTEST Shell project, funded by HIV in Europe, which expands the activities to sites in Belarus, Georgia and the Ukraine.
MEDFASH brought its expertise in HIV and sexual healthcare to the development of educational tools for the OptTEST project. Because of its closure in December 2016, MEDFASH withdrew from OptTEST at the end of November 2016.
MEDFASH was fortunate in receiving matched funding for this initiative in the form of unrestricted grants from ViiV Healthcare UK Ltd and Gilead Sciences Europe Ltd. Neither company had any input into, or control over, the outputs produced for the project.
More information about the OptTEST project can be found at www.opttest.eu or by clicking the link below